BBA

Baker Bros. Advisors Portfolio holdings

AUM $10.3B
1-Year Est. Return 63.34%
This Quarter Est. Return
1 Year Est. Return
+63.34%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$8.79B
AUM Growth
-$8.56B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
105
New
Increased
Reduced
Closed

Top Buys

1
+$159M
2
+$98.3M
3
+$70.5M
4
CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
+$67.8M
5
REPL icon
Replimune Group
REPL
+$41.9M

Top Sells

1
+$9.45B
2
+$337M
3
+$198M
4
SWTX
SpringWorks Therapeutics
SWTX
+$69.4M
5
ROIV icon
Roivant Sciences
ROIV
+$48.1M

Sector Composition

1 Healthcare 98.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$2.27B 25.85%
36,179,122
+556
2
$1.91B 21.69%
10,568,897
-1,100,000
3
$1.34B 15.27%
42,864,612
4
$456M 5.19%
1,969,798
+424,685
5
$294M 3.35%
6,398,365
-303,984
6
$242M 2.76%
4,121,440
+2,711,656
7
$172M 1.96%
2,520,731
8
$153M 1.74%
5,995,928
+1,245,528
9
$148M 1.68%
5,148,657
+2,457,164
10
$131M 1.49%
22,909,753
+2,146,430
11
$85.3M 0.97%
7,593,024
-4,284,147
12
$80.5M 0.92%
9,545,336
+4,967,056
13
$73.4M 0.84%
4,865,819
14
$70.1M 0.8%
1,466,547
+100,000
15
$67.8M 0.77%
+1,600,000
16
$61.5M 0.7%
5,838,853
+198,037
17
$60.7M 0.69%
10,126,176
-2,584,642
18
$57.5M 0.65%
151,215
19
$56M 0.64%
2,607,196
+315,193
20
$55.3M 0.63%
2,368,378
21
$52.6M 0.6%
17,310,490
22
$49.3M 0.56%
2,809,577
23
$45.8M 0.52%
993,679
+242,040
24
$43.2M 0.49%
10,123,824
25
$42.1M 0.48%
19,477,339
+2,237,838
1
2 3 4 5